VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TMCI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TMCITreace Medical Concepts, Inc.
$4.41$286M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTMCIQuarterly Financials

Treace Medical Concepts, Inc. (TMCI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Treace Medical Concepts, Inc. (TMCI) quarterly income statement — complete revenue, gross profit & net income history

TMCI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue47.2M62.52M50.21M47.39M52.57M68.71M45.09M44.45M51.11M62.21M40.76M41.95M42.2M49.77M33.05M29.97M29.05M33.44M21.62M20.65M
Revenue Growth %-10.22%-9.01%11.37%6.6%2.86%10.44%10.62%5.96%21.12%25%23.3%40%45.26%48.84%52.9%45.09%55.27%38.72%--
Cost of Goods Sold9.79M12.12M10.51M9.63M10.68M13.23M8.95M8.78M10.13M11.47M8M7.67M8.04M9.74M6.09M5.29M5.13M6.31M4.25M3.94M
COGS % of Revenue20.74%19.38%20.93%20.33%20.31%19.26%19.86%19.75%19.81%18.44%19.62%18.29%19.05%19.57%18.42%17.66%17.66%18.86%19.65%19.1%
Gross Profit37.41M50.4M39.71M37.75M41.89M55.48M36.13M35.67M40.98M50.74M32.76M34.28M34.16M40.03M26.96M24.68M23.92M27.13M17.37M16.71M
Gross Margin %79.26%80.62%79.07%79.67%79.69%80.74%80.14%80.25%80.19%81.56%80.38%81.71%80.95%80.43%81.58%82.34%82.34%81.14%80.35%80.9%
Gross Profit Growth %-10.71%-9.15%9.89%5.83%2.23%9.33%10.29%4.07%19.98%26.77%21.49%38.91%42.81%47.53%55.23%47.67%55.51%42.64%--
Operating Expenses54.57M56.32M55.38M54.73M57.48M55.68M51.27M57.06M59.95M57.52M50.58M47.33M47.93M43.52M38.28M36.61M32.01M32.73M22.83M20.76M
OpEx % of Revenue115.63%90.09%110.29%115.49%109.33%81.04%113.71%128.35%117.3%92.47%124.09%112.82%113.6%87.45%115.82%122.16%110.21%97.88%105.61%100.52%
Selling, General & Admin49.95M51.78M49.7M49.23M51.91M50.47M46.3M51.9M54.69M53.37M46.23M43.8M44.52M39.77M34.48M33.63M28.96M29.35M20.29M18.34M
SG&A % of Revenue105.83%82.82%98.98%103.89%98.75%73.46%102.7%116.75%107.01%85.79%113.42%104.41%105.51%79.92%104.32%112.21%99.7%87.78%93.87%88.79%
Research & Development4.62M4.54M4.68M5.5M5.56M5.21M4.96M5.16M5.26M4.15M4.35M3.53M3.41M3.75M3.8M2.98M3.05M3.38M2.54M2.42M
R&D % of Revenue9.79%7.27%9.32%11.6%10.58%7.58%11.01%11.6%10.29%6.67%10.67%8.4%8.09%7.53%11.49%9.96%10.51%10.1%11.73%11.73%
Other Operating Expenses001000K00000000000000000
Operating Income-17.17M-5.92M-15.68M-16.97M-15.58M-204K-15.13M-21.38M-18.97M-6.78M-17.82M-13.05M-13.78M-3.5M-11.32M-11.93M-8.1M-5.6M-5.46M-4.05M
Operating Margin %-36.37%-9.47%-31.22%-35.82%-29.64%-0.3%-33.57%-48.1%-37.11%-10.9%-43.72%-31.11%-32.65%-7.03%-34.24%-39.82%-27.87%-16.74%-25.26%-19.61%
Operating Income Growth %-10.17%-2802.94%-3.58%20.62%17.85%96.99%15.06%-63.82%-37.69%-93.94%-57.43%-9.38%-70.16%37.52%-107.29%-194.57%-477.46%-253.98%--
EBITDA-16.27M-3.04M-12.9M-14.4M-13.12M2.03M-12.98M-19.27M-17.06M-5.01M-16.25M-11.96M-12.85M-2.58M-10.86M-11.51M-7.76M-5.32M-5.27M-3.95M
EBITDA Margin %-34.47%-4.86%-25.69%-30.38%-24.96%2.96%-28.78%-43.34%-33.38%-8.06%-39.88%-28.5%-30.46%-5.18%-32.85%-38.41%-26.72%-15.91%-24.38%-19.13%
EBITDA Growth %-23.98%-249.58%0.61%25.27%23.08%140.55%20.16%-61.13%-32.73%-94.3%-49.68%-3.88%-65.58%51.51%-106.01%-191.32%-504.05%-238.46%--
D&A (Non-Cash Add-back)899K2.88M2.78M2.58M2.46M2.24M2.16M2.12M1.91M1.77M1.56M1.09M924K917K459K423K334K276K189K100K
EBIT-17.17M-8.04M-14.95M-16.08M-14.61M813K-14.05M-19.89M-17.36M-4.98M-16.23M-10.99M-12.17M-3.1M-10.94M-16.29M-8.09M-5.59M-5.46M-4.04M
Net Interest Income-1.07M-823K-704K-546K-470K-415K-246K64K218K405K274K686K194K-915K-770K-815K-942K-1.02M-958K-1.03M
Interest Income501K527K634K775K841K899K1.07M1.38M1.53M1.71M1.57M1.97M1.48M396K420K131K11K6K5K6K
Interest Expense1.57M1.35M1.34M1.32M1.31M1.31M1.31M1.31M1.32M1.3M1.3M1.28M1.28M1.31M1.19M946K951K1.03M963K1.04M
Other Income/Expense-794K-3.47M-612K-424K-340K-297K-226K176K292K501K297K781K322K-915K-815K-5.3M-940K-1.02M-958K-1.03M
Pretax Income-17.96M-9.39M-16.29M-17.4M-15.92M-501K-15.36M-21.21M-18.68M-6.28M-17.52M-12.27M-13.45M-4.41M-12.13M-17.23M-9.04M-6.62M-6.42M-5.08M
Pretax Margin %-38.05%-15.03%-32.44%-36.71%-30.29%-0.73%-34.07%-47.7%-36.54%-10.1%-42.99%-29.25%-31.89%-8.87%-36.71%-57.51%-31.11%-19.79%-29.69%-24.61%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-17.96M-9.39M-16.29M-17.4M-15.92M-501K-15.36M-21.21M-18.68M-6.28M-17.52M-12.27M-13.45M-4.41M-12.13M-17.23M-9.04M-6.62M-6.42M-5.08M
Net Margin %-38.05%-15.03%-32.44%-36.71%-30.29%-0.73%-34.07%-47.7%-36.54%-10.1%-42.99%-29.25%-31.89%-8.87%-36.71%-57.51%-31.11%-19.79%-29.69%-24.61%
Net Income Growth %-12.81%-1775.05%-6.04%17.96%14.75%92.02%12.33%-72.81%-38.81%-42.36%-44.41%28.8%-48.89%33.34%-89.05%-239.05%-271.55%-357.85%--
Net Income (Continuing)-17.96M-9.39M-16.29M-17.4M-15.92M-501K-15.36M-21.21M-18.68M-6.28M-17.52M-12.27M-13.45M-4.41M-12.13M-17.23M-9.04M-6.62M-6.42M-5.08M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.28-0.15-0.26-0.28-0.25-0.01-0.25-0.34-0.30-0.10-0.28-0.20-0.22-0.06-0.23-0.31-0.18-0.12-0.12-0.10
EPS Growth %-12%--4%17.65%16.67%92%10.71%-70%-36.36%-58.98%-21.74%35.48%-22.22%47.58%-91.67%-210%-273.44%-335.29%--
EPS (Basic)-0.28-0.15-0.26-0.28-0.25-0.01-0.25-0.34-0.30-0.10-0.28-0.20-0.22-0.06-0.23-0.31-0.18-0.12-0.12-0.10
Diluted Shares Outstanding64.59M63.86M63.52M63.01M62.66M62.34M62.23M62.08M61.79M61.7M61.56M61.38M58.72M55.56M55.43M55.31M54.83M53.62M52.77M49.19M
Basic Shares Outstanding64.59M63.86M63.52M63.01M62.66M62.34M62.23M62.08M61.79M61.7M61.56M61.38M58.72M55.56M55.43M55.31M54.83M53.62M52.77M49.19M
Dividend Payout Ratio--------------------